DK200001897A - Fremgangsmåde til aktivering af genteknologisk fremstillede, heterologe, disulfidbroer indeholdende eukaryotiske proteiner - Google Patents
Fremgangsmåde til aktivering af genteknologisk fremstillede, heterologe, disulfidbroer indeholdende eukaryotiske proteiner Download PDFInfo
- Publication number
- DK200001897A DK200001897A DK200001897A DKPA200001897A DK200001897A DK 200001897 A DK200001897 A DK 200001897A DK 200001897 A DK200001897 A DK 200001897A DK PA200001897 A DKPA200001897 A DK PA200001897A DK 200001897 A DK200001897 A DK 200001897A
- Authority
- DK
- Denmark
- Prior art keywords
- pref
- denaturing
- esp
- disulfide bridges
- eukaryotic proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Lubricants (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Description
PATENTKRAV 1. Fremgangsmåde til aktivering af heterologe, disulfidbro-holdige eukaryotiske proteiner, fremstillet genteknologisk ved ekspression i prokaryotiske celler ved a) oplukning af de prokaryotiske celler, b) opløsning af de eukaryotiske proteiner under denaturerende og reducerende betingelser, c) fraskillelse af de reducerende/denaturerende midler, d) reaktivering under oxiderende betingelser ved e) omdannelse af de solubiliserede proteiners thiol-grupper til de blandede disulfider af protein og glutation ved tilsætning af GSSG under denaturerende betingelser, f) dannelse af aktivt protein ud fra de blandede disulfider ved en GSH-koncentration på 0,5 til 5 mmol/1, en pH-værdi på 7 til 10,5 og i nærværelse af en ikke-dena-turerende koncentration af et denatueringsmiddel. 2. Fremgangsmåde ifølge krav 1, kendetegnet ved, at man gennemfører ekspressionen i E. coli eller P. putida. 3. Fremgangmåde ifølge krav 1 eller 2, kendetegnet ved, at man i reaktiveringstrinnet som denatureringsmiddel anvender arginin, guanidin-hydrochlorid og/eller mindst en forbindelse med den almene formel R2-CO-NRRi (I), hvor R og R, er H eller alkyl med 1 til 4 C-atomer, og R2 er H eller NHR, eller alkyl med 1 til 3 C-atomer. 4. Fremgangsmåde ifølge krav 3, kendetegnet ved, at koncentrationen af arginin og/eller guanidin-hydrochlorid andrager 0,1 til 1,0 mol/1, navnlig 0,25 til 0,8 mol/1. 5. Fremgangsmåde ifølge krav 3, kendetegnet ved, at koncentrationen af forbindelsen med den almene formel I andrager 0,5 til 4 mol/1, navnlig 1 til 3,5 mol/1. 6. Fremgangsmåde ifølge ethvert af de foregående krav, kendetegnet ved, at der ved reaktiveringstrinnet arbejdes ved tilstedeværelse af et ikke-proteolytisk virksomt protein, navnlig ved tilstedeværelse af okseserumalbumin. 7. Fremgangsmåde ifølge ethvert af de foregående krav, kendetegnet ved, at man gennemfører celleoplukningen ved hjælp af ultralyd, højttryksdispersion eller Iysozym. 8. Fremgangsmåde ifølge krav 7, kendetegnet ved, at man gennemfører oplukningen i en fortyndet vandig pufferopløsning, navnlig i 0,1 mol/1 Tris, ved en neutral til svagt sur pH-værdi. 9. Fremgangsmåde ifølge ethvert af de foregående krav, kendetegnet ved, at man efter celleoplukningen fraskiller de uopløselige bestanddele. 10. Fremgangsmåde ifølge ethvert af de foregående krav, kendetegnet ved, at man gennemfører solubiliseringstrinnet ved alkalisk pH-værdi i nærværelse af et reduktionsmiddel fra mercaptogruppen og i nærværelse af et denatureringsmiddel. 11. Fremgangsmåde ifølge krav 10, kendetegnet ved, at man arbejder i nærværelse af guanidin-hydrochlorid og/eller forbindelser med den almene formel I som denatureringsmiddel. 12. Fremgangsmåde ifølge krav 11, kendetegnet ved, at koncentrationen af guanidindhydrochlorid andrager 6 mol/1, koncentration af forbindelser med den almene formel I andrager 8 mol/I. 13. Fremgangsmåde ifølge ethvert af kravene 10 til 12, kendetegnet ved, at man arbejder ved tilstedeværelse af DTE, β-mercaptoethanol, cystein eller GSH. 14. Fremgangsmåde ifølge ethvert af de foregående krav, kendetegnet ved, at man gennemfører rensning og fraskillelse af reduktions-, oxidations- eller denaturerings-midler ved hjælp af sterisk udelukkelseschromatografi eller dialyse. 15. Fremgangsmåde ifølge ethvert af de foregående krav, kendetegnet ved, at man efter reaktiveringstrinnet gennemfører et rensningstrin ved hjælp af dialyse. 16. Fremgangsmåde ifølge ethvert af kravene 1 til 15, k e n d e t e g n e t ved, at man som genteknologisk fremstillet eukaryotisk protein anvender t-PA. 17. Stimulerbar, ikke-glycosyleret tPA, opnået i overensstemmelse med fremgangsmåden ifølge ethvert af kravene 1 til 16. 18. Fremgangsmåde ifølge krav 6, kendetegnet ved, at man ved hjælp af ionbyt-terbehandling fraskiller det blandede disulfid af protein og glutathion fra ik-ke-modificeret protein.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3537708 | 1985-10-23 | ||
DE19853537708 DE3537708A1 (de) | 1985-10-23 | 1985-10-23 | Verfahren zur aktivierung von t-pa nach expression in prokaryonten |
DK198703203A DK175091B1 (da) | 1985-10-23 | 1987-06-23 | Fremgangsmåde til aktivering af genteknologisk fremstillede, heterologe, disulfidbro-holdige eukaryotiske proteiner efter ekspression i prokaryotiske celler |
DK320387 | 1987-06-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK200001897A true DK200001897A (da) | 2000-12-18 |
DK175109B1 DK175109B1 (da) | 2004-06-07 |
Family
ID=6284269
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198703203A DK175091B1 (da) | 1985-10-23 | 1987-06-23 | Fremgangsmåde til aktivering af genteknologisk fremstillede, heterologe, disulfidbro-holdige eukaryotiske proteiner efter ekspression i prokaryotiske celler |
DK200001897A DK175109B1 (da) | 1985-10-23 | 2000-12-18 | Fremgangsmåde til aktivering af genteknologisk fremstillede, heterologe, disulfidbroer indeholdende eukaryotiske proteiner efter ekspression i prokaryotiske celler |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198703203A DK175091B1 (da) | 1985-10-23 | 1987-06-23 | Fremgangsmåde til aktivering af genteknologisk fremstillede, heterologe, disulfidbro-holdige eukaryotiske proteiner efter ekspression i prokaryotiske celler |
Country Status (26)
Country | Link |
---|---|
EP (3) | EP0219874B1 (da) |
JP (2) | JPH0728745B2 (da) |
KR (1) | KR900009139B1 (da) |
AT (2) | ATE131489T1 (da) |
AU (2) | AU590029B2 (da) |
CA (1) | CA1329157C (da) |
CZ (1) | CZ280727B6 (da) |
DD (1) | DD260517A5 (da) |
DE (3) | DE3537708A1 (da) |
DK (2) | DK175091B1 (da) |
ES (2) | ES2020498T3 (da) |
FI (2) | FI94050C (da) |
GR (2) | GR920300062T1 (da) |
HK (2) | HK153496A (da) |
HR (1) | HRP921075B1 (da) |
HU (2) | HUT43643A (da) |
IE (1) | IE62634B1 (da) |
IL (1) | IL80325A (da) |
PT (1) | PT83609B (da) |
SI (1) | SI8611796B (da) |
SK (1) | SK278317B6 (da) |
SU (1) | SU1607689A3 (da) |
UA (1) | UA6023A1 (da) |
WO (1) | WO1987002673A2 (da) |
YU (1) | YU47185B (da) |
ZA (1) | ZA868012B (da) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4766205A (en) * | 1985-11-13 | 1988-08-23 | Beatrice Companies, Inc. | Method for isolation of recombinant polypeptides in biologically active forms |
JP2581668B2 (ja) * | 1985-11-27 | 1997-02-12 | 三井東圧化学株式会社 | ヒト正常細胞由来のヒト組織プラスミノ−ゲン活性化因子をコ−ドする新しいdna配列とそれを含むベクタ−及び細胞 |
US4777043A (en) * | 1985-12-17 | 1988-10-11 | Genentech, Inc. | Stabilized human tissue plasminogen activator compositions |
AU621051B2 (en) | 1987-04-28 | 1992-03-05 | Amgen, Inc. | Method for purifying granulocyte-macrophage colony stimulating factor |
DE3722082A1 (de) * | 1987-07-03 | 1989-01-12 | Behringwerke Ag | Verfahren zur bestimmung der aktivitaet von serinproteasen oder serinproteaseinhibitoren |
CA1340586C (en) * | 1988-09-23 | 1999-06-08 | Cetus Corporation | Process for recovering microbially produced interferon-beta |
DE3832898A1 (de) * | 1988-09-28 | 1990-04-12 | Boehringer Mannheim Gmbh | Praeparat von in prokaryonten exprimiertem plasminogenaktivator |
DE3835350A1 (de) * | 1988-10-17 | 1990-04-19 | Boehringer Mannheim Gmbh | Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern |
DE3903581A1 (de) * | 1989-02-07 | 1990-08-16 | Boehringer Mannheim Gmbh | Gewebs-plasminogenaktivator-derivat |
DE3942143A1 (de) * | 1989-12-20 | 1991-06-27 | Boehringer Mannheim Gmbh | T-pa pro stabilisierung |
ATE154073T1 (de) * | 1990-08-20 | 1997-06-15 | Novo Nordisk As | Prozess für die herstellung von biologisch aktivem igf-1 durch verwendung von amino-terminal verlängertem igf-1 |
DE69129747T2 (de) * | 1990-09-05 | 1998-11-12 | Southern Cross Biotech Pty Ltd | In lösung bringen von proteinen in aktiver form |
DE4037196A1 (de) * | 1990-11-22 | 1992-05-27 | Boehringer Mannheim Gmbh | Verfahren zur reaktivierung von denaturiertem protein |
DE4113750A1 (de) | 1991-04-26 | 1992-10-29 | Boehringer Mannheim Gmbh | Verbesserung der renaturierung bei der sekretion von disulfidverbrueckten proteinen |
DE4139000A1 (de) | 1991-11-27 | 1993-06-03 | Boehringer Mannheim Gmbh | Verfahren zur gentechnologischen herstellung von biologisch aktivem ss-ngf |
US5212091A (en) * | 1992-03-02 | 1993-05-18 | Monsanto Company | Method of producing tissue factor pathway inhibitor |
WO1993019084A1 (en) * | 1992-03-24 | 1993-09-30 | Synergen, Inc. | Refolding and purification of insulin-like growth factor i |
EP0600372B1 (de) | 1992-12-02 | 1997-02-05 | Hoechst Aktiengesellschaft | Verfahren zur Gewinnung von Proinsulin mit korrekt verbundenen Cystinbrücken |
DE4405179A1 (de) * | 1994-02-18 | 1995-08-24 | Hoechst Ag | Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken |
FR2729972B1 (fr) * | 1995-01-31 | 1997-04-18 | Sanofi Sa | Procede d'extraction de proteines periplasmiques de microorganismes procaryotes en presence d'arginine |
US5714371A (en) * | 1995-05-12 | 1998-02-03 | Schering Corporation | Method for refolding insoluble aggregates of hepatitis C virus protease |
US5728804A (en) * | 1995-06-02 | 1998-03-17 | Research Corporation Technologies, Inc. | Use of cyclodextrins for protein renaturation |
CA2257122C (en) * | 1996-06-11 | 2004-04-06 | Boehringer Mannheim Gmbh | Method of activating denatured protein |
US7153943B2 (en) | 1997-07-14 | 2006-12-26 | Bolder Biotechnology, Inc. | Derivatives of growth hormone and related proteins, and methods of use thereof |
US6653098B1 (en) * | 1998-02-23 | 2003-11-25 | G. D. Searle & Co. | Method of producing mouse and human endostatin |
DE19850429A1 (de) * | 1998-10-27 | 2000-05-04 | Andre Schrattenholz | Fragmente |
EP1048732A1 (de) * | 1999-04-26 | 2000-11-02 | F. Hoffmann-La Roche Ag | Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen |
EP1077263A1 (de) * | 1999-07-29 | 2001-02-21 | F.Hoffmann-La Roche Ag | Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen durch Co-Sekretion von Chaperonen |
DE60129432T2 (de) | 2000-05-16 | 2008-04-17 | Bolder Biotechnology, Inc., Louisville | Verfahren zur rückfaltung von proteinen mit freien cysteinresten |
DE10105912A1 (de) * | 2001-02-09 | 2002-08-14 | Roche Diagnostics Gmbh | Rekombinante Proteinase K |
DE10105911A1 (de) | 2001-02-09 | 2002-08-14 | Roche Diagnostics Gmbh | Expression der rekombinanten Proteinase K aus Tritirachium album in Hefe |
DE102005033250A1 (de) | 2005-07-15 | 2007-01-18 | Bioceuticals Arzneimittel Ag | Verfahren zur Reinigung von G-CSF |
DE202006020194U1 (de) | 2006-03-01 | 2007-12-06 | Bioceuticals Arzneimittel Ag | G-CSF-Flüssigformulierung |
WO2008008975A2 (en) | 2006-07-14 | 2008-01-17 | Genentech, Inc. | Refolding of recombinant proteins |
EP2102355B1 (en) | 2006-12-14 | 2016-03-02 | Bolder Biotechnology, Inc. | Long acting proteins and peptides and methods of making and using the same |
AU2011229491B2 (en) | 2010-03-17 | 2015-02-05 | Ratiopharm Gmbh | Method for obtaining biologically active recombinant human G-CSF |
WO2012054679A1 (en) * | 2010-10-20 | 2012-04-26 | Medimmune, Llc | Methods for processing inclusion bodies |
HUP1200171A1 (hu) | 2012-03-19 | 2013-09-30 | Richter Gedeon Nyrt | Módszerek polipeptidek elõállítására |
HUP1200172A2 (en) | 2012-03-19 | 2013-10-28 | Richter Gedeon Nyrt | Methods for refolding g-csf from inclusion bodies |
CN103852527B (zh) * | 2012-12-05 | 2015-05-13 | 中国科学院大连化学物理研究所 | 一种高通量蛋白质样品预处理装置 |
US10457716B2 (en) | 2014-08-06 | 2019-10-29 | University Of Notre Dame Du Lac | Protein folding and methods of using same |
NZ746109A (en) | 2016-12-30 | 2022-12-23 | Biogend Therapeutics Co Ltd | Recombinant polypeptides and nucleic acid molecules, compositions, and methods of making and uses thereof |
WO2022129460A1 (en) | 2020-12-18 | 2022-06-23 | Richter Gedeon Nyrt. | Methods for the purification of refolded fc-peptide fusion protein |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5135481A (ja) * | 1974-09-18 | 1976-03-25 | Fujiwa Kako Kk | Kojundohitorokinaaze no seiho |
US4468633A (en) | 1982-04-28 | 1984-08-28 | The Bendix Corporation | Adjustable microwave power combiner for a plurality of coaxially mounted impatt diodes |
AR241654A1 (es) | 1982-05-05 | 1992-10-30 | Genentech Inc | Procedimiento para producir activador de plasminogeno de tejido humano. |
US4432895A (en) * | 1982-11-24 | 1984-02-21 | Hoffmann-La Roche Inc. | Monomeric interferons |
GR79124B (da) * | 1982-12-22 | 1984-10-02 | Genentech Inc | |
WO1984003711A1 (en) * | 1983-03-25 | 1984-09-27 | Celltech Ltd | A process for the production of a protein |
JPS6051119A (ja) * | 1983-08-30 | 1985-03-22 | Green Cross Corp:The | ウロキナ−ゼ乾燥製剤 |
US4530787A (en) * | 1984-03-28 | 1985-07-23 | Cetus Corporation | Controlled oxidation of microbially produced cysteine-containing proteins |
US4748234A (en) * | 1985-06-26 | 1988-05-31 | Cetus Corporation | Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
US4766205A (en) * | 1985-11-13 | 1988-08-23 | Beatrice Companies, Inc. | Method for isolation of recombinant polypeptides in biologically active forms |
FR2596360B1 (fr) * | 1986-04-01 | 1989-02-17 | Sotralentz Sa | Conteneur sur palette avec dispositif de protection en treillis plie et renforce |
JPH0651119A (ja) * | 1992-07-28 | 1994-02-25 | Sekisui Chem Co Ltd | 位相差板の製造方法 |
-
1985
- 1985-10-23 DE DE19853537708 patent/DE3537708A1/de active Granted
-
1986
- 1986-10-10 IE IE268386A patent/IE62634B1/en not_active IP Right Cessation
- 1986-10-15 IL IL80325A patent/IL80325A/xx not_active IP Right Cessation
- 1986-10-17 CZ CS867526A patent/CZ280727B6/cs not_active IP Right Cessation
- 1986-10-17 SK SK7526-86A patent/SK278317B6/sk unknown
- 1986-10-21 YU YU179686A patent/YU47185B/sh unknown
- 1986-10-21 SI SI8611796A patent/SI8611796B/sl unknown
- 1986-10-22 ZA ZA868012A patent/ZA868012B/xx unknown
- 1986-10-22 DD DD29546886A patent/DD260517A5/de not_active IP Right Cessation
- 1986-10-22 CA CA000521121A patent/CA1329157C/en not_active Expired - Lifetime
- 1986-10-23 ES ES90109721T patent/ES2020498T3/es not_active Expired - Lifetime
- 1986-10-23 JP JP61505882A patent/JPH0728745B2/ja not_active Expired - Lifetime
- 1986-10-23 UA UA4202987A patent/UA6023A1/uk unknown
- 1986-10-23 AT AT90109721T patent/ATE131489T1/de not_active IP Right Cessation
- 1986-10-23 WO PCT/EP1986/000610 patent/WO1987002673A2/de active IP Right Grant
- 1986-10-23 HU HU865290A patent/HUT43643A/hu unknown
- 1986-10-23 AT AT86114731T patent/ATE98648T1/de not_active IP Right Cessation
- 1986-10-23 ES ES86114731T patent/ES2061434T3/es not_active Expired - Lifetime
- 1986-10-23 AU AU65993/86A patent/AU590029B2/en not_active Ceased
- 1986-10-23 EP EP86114731A patent/EP0219874B1/de not_active Expired - Lifetime
- 1986-10-23 DE DE3650449T patent/DE3650449D1/de not_active Expired - Lifetime
- 1986-10-23 EP EP90109721A patent/EP0393725B1/de not_active Expired - Lifetime
- 1986-10-23 PT PT83609A patent/PT83609B/pt not_active IP Right Cessation
- 1986-10-23 EP EP86906320A patent/EP0253823A1/de active Pending
- 1986-10-23 DE DE86114731T patent/DE3689404D1/de not_active Expired - Lifetime
- 1986-10-23 HU HU865290A patent/HU204855B/hu unknown
- 1986-10-23 KR KR1019870700536A patent/KR900009139B1/ko not_active IP Right Cessation
-
1987
- 1987-06-22 SU SU874202987Q patent/SU1607689A3/ru active
- 1987-06-22 FI FI872753A patent/FI94050C/fi not_active IP Right Cessation
- 1987-06-23 DK DK198703203A patent/DK175091B1/da not_active IP Right Cessation
-
1989
- 1989-09-13 AU AU41321/89A patent/AU607083B2/en not_active Expired
-
1991
- 1991-04-12 JP JP3079762A patent/JPH0824594B2/ja not_active Expired - Lifetime
-
1992
- 1992-08-31 GR GR92300062T patent/GR920300062T1/el unknown
- 1992-10-16 HR HRP-1796/86A patent/HRP921075B1/xx not_active IP Right Cessation
-
1993
- 1993-09-03 FI FI933868A patent/FI95578C/fi not_active IP Right Cessation
-
1995
- 1995-12-14 GR GR950403376T patent/GR3018410T3/el unknown
-
1996
- 1996-08-08 HK HK153496A patent/HK153496A/xx not_active IP Right Cessation
- 1996-08-08 HK HK153596A patent/HK153596A/xx not_active IP Right Cessation
-
2000
- 2000-12-18 DK DK200001897A patent/DK175109B1/da not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK200001897A (da) | Fremgangsmåde til aktivering af genteknologisk fremstillede, heterologe, disulfidbroer indeholdende eukaryotiske proteiner | |
KR900006515A (ko) | 유전자 공학적으로 생성되고 원핵생물내 발현된 항체의 활성화 방법 | |
DE69934585D1 (de) | Rückfaltung von protein-aggregaten und einschlussteilchen durch hohen druck | |
CA2090701C (en) | Solubilization of proteins in active forms | |
AU2002340510A1 (en) | Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines | |
EP0804461A1 (en) | Process for folding of proteins like recombinant hirudin or epidermal growth factor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |